Mycotopia Therapies (20/20 Global) to Launch PsyBioMed, a Biosynthetic Compound, a Biotech Company for the Global Production of Psychedelics
08 févr. 2021 08h30 HE
|
20/20 Global, Inc.
MIAMI, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies (20/20 Global, Inc.), (OTC Pink: TWGL), a company focused on psychedelic therapies, is establishing a biosynthetic compound subsidiary...
20/20 Global, Inc. PsyTech the World’s Most Recognized Psychedelic Conference to Host Live Webinar on New Approaches to Ketamine-Assisted Treatment Wednesday, January 27th 2021 at 12:00 EST
26 janv. 2021 08h30 HE
|
20/20 Global, Inc.
MIAMI, Jan. 26, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc., (OTC Pink: TWGL) (the “Company”) announced today an upcoming complimentary Psychedelic Industry webinar for investors and interested...